Loomis Sayles & CO L P Veracyte, Inc. Transaction History

Loomis Sayles & CO L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$44.47 - $81.38 $47.4 Million - $86.7 Million	-1,065,939 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$32.49 - $61.88 $203,907 - $388,358	-6,276 Reduced 0.59%	1,065,939 $52.2 Million
Q3 2020 Nov 12, 2020	BUY	$26.73 - $35.67 $3.62 Million - $4.83 Million	135,420 Added 14.46%	1,072,215 $34.8 Million
Q2 2020 Aug 14, 2020	BUY	$19.49 - $28.11 $4.14 Million - $5.97 Million	212,522 Added 29.34%	936,795 $24.3 Million
Q1 2020 May 15, 2020	BUY	$16.13 - $30.17 $11.7 Million - $21.9 Million	724,273 New	724,273 $17.6 Million

254

82.1M

42.3K

18.2K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.42B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.